(Q42445609)

31 October 2017

title

Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats (English)

1 reference

31 October 2017

Jennifer Altomonte

1

1 reference

31 October 2017

Sonal Harbaran

series ordinal

2

1 reference

31 October 2017

Anja Richter

series ordinal

3

1 reference

31 October 2017

Hengjiang Dong

series ordinal

4

1 reference

31 October 2017

publication date

1 August 2003

1 reference

31 October 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

31 October 2017

volume

52

1 reference

31 October 2017

issue

8

1 reference

31 October 2017

page(s)

958-963

1 reference

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

ACRP30, a new hormone controlling fat and glucose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Resistin and obesity-associated insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Leptin: the tale of an obesity gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

TNF-alpha and insulin resistance: summary and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

The expression of adipogenic genes is decreased in obesity and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Adiponectin and development of type 2 diabetes in the Pima Indian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Regional differences in the control of lipolysis in human adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Insulin resistance in obesity: metabolic mechanisms and measurement methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Tumor necrosis factor stimulates hepatic lipid synthesis and secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

CYTOKINES INHIBIT FATTY ACID OXIDATION IN ISOLATED RAT HEPATOCYTES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

Gene expression in visceral and subcutaneous adipose tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900092-1

10.1016/S0026-0495(03)00092-1

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference